Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Classifica tra le azioni #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Prezzo delle azioni
$0.00001
Ultima sincronizzazione: 2026-09-10
Capitalizzazione di mercato
$50.01K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia MultiCell Technologies, Inc. (MCET)

Categoria

Storico del prezzo dell'azione per MultiCell Technologies, Inc. (MCET)
Prezzo di chiusura più alto: $0.00 il 2026-09-01

Prezzo di chiusura più basso: $0.70 il 2000-01-01
Storico del prezzo dell'azione di MultiCell Technologies, Inc. dal 2000 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 -89.96%
2024 542.72%
2023 -58.24%
2022 0.00%
2021 -58.10%
2020 156.99%
2019 -7.14%
2018 -41.18%
2017 -16.78%
2016 -6.37%
2015 -36.84%
2014 -38.00%
2013 -58.42%
2012 -72.33%
2011 13.46%
2010 -68.39%
2009 150.51%
2008 -86.27%
2007 -83.63%
2006 -60.50%
2005 -31.77%
2004 -70.68%
2003 719.22%
2002 -33.40%
2001 -14.26%
2000 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$515.86 30.75%
US
$987.47 30.55%
NL
$146.64 523.73%
US
$117.15 -15.24%
AU
$690.34 0.44%
CH